DOCETAXEL (Ingenus Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the DOCETAXEL drug offered from Ingenus Pharmaceuticals, LLC. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ingenus Pharmaceuticals, LLC
NON-PROPRIETARY NAME: DOCETAXEL ANHYDROUS
SUBSTANCE NAME: DOCETAXEL ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-09-07
END MARKETING DATE: 0000-00-00


DOCETAXEL HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDOCETAXEL from Ingenus Pharmaceuticals, LLC
LABELER NAME: Ingenus Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2017-09-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50742-428_b598d9f9-09d4-48a8-bc07-5595890cdae9
PRODUCT NDC: 50742-428
APPLICATION NUMBER: ANDA207563

Other DOCETAXEL ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Docetaxel
Hospira, Inc.Docetaxel
Ingenus Pharmaceuticals, LLCDOCETAXEL
McKesson Packaging Services a business unit of McKesson CorporationDocetaxel
Northstar RxLLCDocetaxel
Sagent PharmaceuticalsDocetaxel
Teva Parenteral Medicines, Inc.Docetaxel